Dr. Lal PathLabs539524New investment
Dr. Lal PathLabs invests up to INR 30.3 crore in WOS PathLabs Unifiers to fund buyout of remaining 30% of CentraPath Labs
30%Remaining equity stake in CentraPath Labs to be acquired
- Cash Consideration
- not exceeding INR 30.3 Crores
- Stake Being Acquired
- remaining 30% equity stake in CentraPath Labs Private Limited (CPL)
- Subsidiary Holding Post Investment
- PUPL shall continue to remain a Wholly Owned Subsidiary (100%) of the Company
- Target
- PathLabs Unifiers Private Limited (PUPL)
- Transaction
- Further Investment in Wholly Owned Subsidiary
Dr. Lal PathLabs invests up to INR 30.3 crore in WOS PathLabs Unifiers to fund buyout of remaining 30% of CentraPath Labs.
7.23 Crores+1.8%
FY20257.10 CroresFY20267.23 Crores
Incorporation of PUPL
Investment by subscribing to shares
Also from Dr. Lal PathLabs
Income Tax Dept appeals before ITAT against relief on ESOP expense disallowance
8 Oct 2026
Update on completion of acquisition of stake in SN Genelab Private Limited
1 Oct 2026
Completes Acquisition of 80% Stake in Sunshine Healthcare, Ghana
26 Sep 2026
More numbers
- Cost of acquisition (cap)Not exceeding INR 30.3 Crores
- PUPL turnover FY 20267.23 Crores
- PUPL turnover FY 20257.10 Crores
- PUPL turnover FY 20247.28 Crores
- Remaining equity stake in CentraPath Labs to be acquired30%
- ConsiderationNot exceeding INR 30.3 Crores
Source: BSE · 12 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.